MARKET OPEN: Covid drug trial sets upbeat tone for local trading

MARKET OPEN: Covid drug trial sets upbeat tone for local trading
Paul McBeth
New Zealand’s stock market may be in for a positive start to the week after Wall Street closed stronger on Friday on optimism over a late-stage trial of the Remdesivir drug in treating covid-19. Investor optimism over the economic recovery from the covid-19 pandemic was stoked by drug company Gilead’s news that its antiviral remdesivir product significantly aided the recovery of severely ill patients. Australia’s Therapeutics Goods Administration gave provisional approval for remdesivir to be used in adults with severe covid symptoms. “Gi...

More Markets

Nvidia slump drags Wall Street and NZ sharemarket lower
Markets Market Close

Nvidia slump drags Wall Street and NZ sharemarket lower

The S&P/NZX 50 Index closed 20 points or 0.15% down at 13,419.40.

RBNZ reopens Wellington office after asbestos mayhem
Finance

RBNZ reopens Wellington office after asbestos mayhem

Bank tight-lipped on how many staff are home-working as asbestos-hit office reopens. 

Oceania Healthcare extends dividend freeze
Markets

Oceania Healthcare extends dividend freeze

The retirement village operator hasn't paid a dividend since June 2023.